4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-22-042573
Chief Scientific Officer sold 46,034 shares at $30.00 ($1,381,020)
- Chief Scientific Officer acquired 46,034 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lachey Jennifer Chief Scientific Officer | 2022-07-15 | Option exercise | +46,034 | $0.30 | $13,810 | 141,134 | D |
| Lachey Jennifer Chief Scientific Officer | 2022-07-15 | Sale | −46,034 | $30.00 | $1,381,020 | 95,100 | D |
| Derivatives | |||||||
| Lachey Jennifer Chief Scientific Officer | 2022-07-15 | Option exercise · Employee Stock Option (right to buy) | −46,034 | 8,755 | D | ||
| Open-market sales · 46,034 sh · avg $30.00 · $1,381,020 | |||||||
Loading xslF345X03/doc4.xml…